Granard Pharmaceutical Sales and Marketing Has Been Retained by SkinMedica Pharmaceuticals Inc for Trade Sales and Marketing Services

Share Article

Granard Pharmaceutical Sales & Marketing announced today it has entered into an agreement with SkinMedica Pharmaceuticals Inc, which is effective March, 2012. Granard has been retained as a trade sales and marketing associate for SkinMedica’s VANIQA® product.

News Image

VANIQA® is the first and only prescription cream clinically proven to reduce and control the growth of unwanted facial hair in women.

About SkinMedica:
SkinMedica, Inc. is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. Colorescience Pro’s dermatologist recommended, high-performance cosmetics are formulated to remedy and camouflage specific skin concerns and protect skin from damaging effects of the sun and environment. Colorescience Pro’s luxury aesthetic makeup line is sold in the physician and medical spa channels.

About Granard:
A privately held company Granard has provided trade, distribution, sales, and marketing representation to both brand and generic pharmaceutical companies for over 15 years. Granard provides manufacturers the opportunity to utilize the brand & generic relationships they have built over the years within the chains, wholesalers, distributors and mail order customers. Granard helps clients achieve rapid market penetration by leveraging our established relationships with more than 120 national points of distribution, including pharmaceutical wholesalers, generic distributors, retail chains and mail order pharmacies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Armand Crupi, Executive Vice President